Publications by authors named "Christophe Demaison"

Claim this Profile
P
Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population.
Francesca A Mercuri, Aowen Zhuang, Hayley A McQuilten, Andrew Jarnicki, Robert O'Donoghue, Christophe Demaison

ERJ Open Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of INNA-051, a TLR2/6 agonist for the prevention of complications resulting from viral respiratory infections.
Francesca A Mercuri, Gary P Anderson, Bruce E Miller, Christophe Demaison, Ruth Tal-Singer

Antiviral Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of intranasal TLR2/6 agonist INNA-051: safety, tolerability and proof of pharmacology.
Francesca A Mercuri, Scott White, Hayley A McQuilten, Charlotte Lemech, Stephan Mynhardt, Christophe Demaison

ERJ Open Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections.
Ruth Tal-Singer, Bruce E Miller, Jean M Rommes, Mark A Luttmann, Christophe Demaison

J Patient Exp· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR2-mediated innate immune priming boosts lung anti-viral immunity.
Jason Girkin, Su-Ling Loo, Camille Esneau, Steven Maltby, Francesca Mercuri, Christophe Demaison

Eur Respir J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.
Georgia Deliyannis, Chinn Yi Wong, Hayley A McQuilten, Annabell Bachem, Michele Clarke, Christophe Demaison

JCI Insight· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.
Pamela C Proud, Daphne Tsitoura, Robert J Watson, Brendon Y Chua, Marilyn J Aram, Christophe Demaison

EBioMedicine· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
Christophe Demaison, Kathryn Parsley, Gaby Brouns, Michaela Scherr, Karin Battmer

Hum Gene Ther· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis